Skip to content
Neroes logo β€” Turning People into Heroes πŸš€
Get a FREE Brain Experience in...

Neroes

Turning People into Heroes πŸš€ Get a FREE Brain Experience in your company🧠

Founded 2020 Portugal Portugal 7 employees Pre-Seed Total: $350.00K Health Care, Medical Devices +1

General Information

Company Name Neroes
Founded Year 2020
Location Portugal Portugal
Founders / Decision Makers
Team member Team member
Employees 7
Industries Health Care, Medical Devices, Sports
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Neroes. To contact Neroes, visit neroes.tech.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neroes compare?

A PDF of Neroes and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neroes soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neroes

Neroes is a Portugal-based startup in the Health Care and Sports industries, founded in 2019. The company's slogan "Where Heroes are made" aligns with their mission to revolutionize brain training for athletes. Neroes has developed a groundbreaking mental training platform that uses wearable technology to read brain waves and adapt a video game to train and enhance an athlete's performance.

Their innovative approach focuses on reducing anxiety and improving emotional control, ultimately boosting athletes' performance. Neroes recently secured a $250.00K pre-seed investment in a round led by Newchip Accelerator and Draper Startup House Ventures on 01 September 2022.

The company's unique combination of neurotechnology and sports training presents an exciting opportunity for investors interested in the intersection of health, technology, and sports. With the potential to revolutionize athlete performance, Neroes is poised to make a significant impact in the sports industry.

Business keywords: Neurofeedback, Performance, Gaming, EEG, Brain Training, Cognitive Performance

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $250.00K 2
Draper Startup House, Newchip Accelerator
01 Sep 2022
Seed Round Β₯100.00K 1
Portugal Ventures
29 Jan 2021

Neroes Alternatives & Competitors

View All Alternatives
Neroes vs
VoxNeuro
VoxNeuro United States

Giving everyone's brain a voice

Corporate Round
9 employees
Health Care, Medical Devices
Neroes vs

Next-gen tools for healthcare

1 employees
Health Care, Medical Devices
Neroes vs

Reinventing brain health. Personalized technologies for brain monitoring and stimulation.

Series A
66 employees
AI, Biotechnology

FAQ About Neroes

Turning People into Heroes πŸš€ Get a FREE Brain Experience in your company🧠
Neroes was founded in 2020.
Neroes is headquartered in Portugal.
Neroes operates in Health Care, Medical Devices and Sports. Its work centres on Neurofeedback, Performance, Gaming and EEG.
Neroes has approximately 7 employees.
Neroes has completed 2 funding rounds, raising a total of $350.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Neroes include VoxNeuro, Drowzee Analytics, Neuroelectrics, Innoria Kft., NeuroServo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neroes and VoxNeuro are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neroes, https://bouncewatch.com/company/neroes, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout